Tenet Guides FY Revenue to $22.05B-$22.45B
THC sits 70% above its 52-week low of $157.58.
Summary
Tenet put a fiscal-year revenue range of $22.05B to $22.45B on the table, the first hard top-line guide in this stretch of coverage, alongside a fiscal-year adjusted EPS outlook of $22.05 to $23.01. The company has been in a guidance-raising pattern: the Q2 8-K in July lifted the full-year outlook and added $2.0 billion to the buyback, and Q1 also came with a raised guide. Third-quarter revenue came in at $5.63B. Balance-sheet work is running in parallel: the $2.0 billion of 6.250% senior notes due 2034 priced in September and settled September 22, redeeming $1.5 billion of 2027 notes and $0.5 billion of other debt. Insiders have been steady sellers through August and September, including the CEO's $27.6 million sale and the COO's $6.39 million sale.
At the time of this announcement, THC was trading at $268.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $21.6B. The 52-week trading range was $157.58 to $283.05. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.